UnknownNot Applicable

Buyang Huanwu Decoction and Normal Tension Glaucoma

60 participantsStarted 2023-10-01

Plain-language summary

The goal of this clinical trial is to test Buyang Huanwu Decoction in normal intra-ocular pressure glaucoma. The main question to answer is: the effect of Buyang Huanwu Decoction and its safety in patients with normal intra-ocular pressure glaucoma. Participants will take 3 grams of Buyang Huanwu Decoction or placebo for 12 weeks. Researchers will compare treatment group and placebo group to see if the visual acuity, visual field would be improved.

Who can participate

Age range20 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosis of normal tension glaucoma for at least 3 months. * Using less than 1 medicine for glaucoma. * Without any eye disease other than normal tension glaucoma. * Writing the Informed Consent Form by themselves. Exclusion Criteria: * With other chronic diseases, such as diabetes, hypertension, cancer. * With polypharmacy. * Had glaucoma surgery or myopia laser surgery before the study. * With mental disease and could not finish the study. * Allergic to Buyang Huanwu Decoction. * Pregnancy or lactation.

What they're measuring

Changes in visual acuity

Timeframe: 12 weeks

Trial details

NCT IDNCT06054763

SponsorChina Medical University Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-10-31

View on ClinicalTrials.gov More Glaucoma trials